Efficacy of Dulaglutide as a First Injectable Option for Patients with Type 2 Diabetes: A Post-Hoc Pooled Analysis

INTRODUCTION: The ADA-EASD consensus report recommends using glucagon-like peptide-1 receptor agonists (GLP-1RAs) as the first injectable therapy prior to basal insulin in most patients with type 2 diabetes (T2D) not at glycemic goals after oral anti-hyperglycemia medications (OH). The objective of...

Descripción completa

Detalles Bibliográficos
Autores principales: Patel, Hiren, Munir, Kashif, Sutherland, Sindee, Karanikas, Chrisanthi A., Konig, Manige
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2019
Materias:
Brief Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6848683/
https://www.ncbi.nlm.nih.gov/pubmed/31605302
http://dx.doi.org/10.1007/s13300-019-00709-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6848683/
https://www.ncbi.nlm.nih.gov/pubmed/31605302
http://dx.doi.org/10.1007/s13300-019-00709-9

Ejemplares similares